Latest News and Press Releases
Want to stay updated on the latest news?
-
Randomized Phase 2 trial initiated for agenT-797 in severe acute lung injury and respiratory distress, with preliminary data expected in the second half of 2026AACR and ASGCT presentations showcase...
-
Randomized Phase 2 trial evaluates off-the-shelf invariant natural killer T (iNKT) cell therapy in patients with acute lung injury and hypoxemic respiratory failure Study initiates in Lviv, Ukraine,...
-
NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma...
-
New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Acute Lung Injury Market: Key InsightsAccording to our new research study on "Acute Lung Injury Market to 2028 – Global Analysis and Forecast – by...
-
LONDON and TAIPEI, Taiwan, June 22, 2016 (GLOBE NEWSWIRE) -- Imagination Technologies (IMG.L) announces that ALi Corporation, a leading set-top box (STB) chipset provider, is shipping a...
-
Study Highlights: Older adults with low income are at increased risk for heart failure. Income status better predicts who develops heart failure than education level. Despite Medicare...